These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16865559)

  • 1. Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.
    Tluczek A; Koscik RL; Modaff P; Pfeil D; Rock MJ; Farrell PM; Lifchez C; Freeman ME; Gershan W; Zaleski C; Sullivan B
    J Genet Couns; 2006 Aug; 15(4):277-91. PubMed ID: 16865559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial Distress and Knowledge Deficiencies in Parents of Children in Ireland Who Carry an Altered Cystic Fibrosis Gene.
    Quigley SJ; Linnane B; Connellan S; Ward A; Ryan P
    J Genet Couns; 2018 Jun; 27(3):589-596. PubMed ID: 28952009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test.
    Lang CW; McColley SA; Lester LA; Ross LF
    Pediatrics; 2011 Feb; 127(2):276-83. PubMed ID: 21220393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine.
    Stalker HJ; Jonasson AR; Hopfer SM; Collins MS
    Pediatr Pulmonol; 2023 Dec; 58(12):3478-3486. PubMed ID: 37712603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.
    Beucher J; Leray E; Deneuville E; Roblin M; Pin I; Bremont F; Turck D; Giniès JL; Foucaud P; Rault G; Derelle J; David V; Journel H; Marchand S; Veillard D; Roussey M
    J Pediatr; 2010 May; 156(5):771-6, 776.e1. PubMed ID: 20171652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.
    Mischler EH; Wilfond BS; Fost N; Laxova A; Reiser C; Sauer CM; Makholm LM; Shen G; Feenan L; McCarthy C; Farrell PM
    Pediatrics; 1998 Jul; 102(1 Pt 1):44-52. PubMed ID: 9651412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.
    Wheeler PG; Smith R; Dorkin H; Parad RB; Comeau AM; Bianchi DW
    Genet Med; 2001; 3(6):411-5. PubMed ID: 11715005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for cystic fibrosis - The parent perspective.
    Rueegg CS; Barben J; Hafen GM; Moeller A; Jurca M; Fingerhut R; Kuehni CE;
    J Cyst Fibros; 2016 Jul; 15(4):443-51. PubMed ID: 26751132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
    Comeau AM; Parad R; Gerstle R; O'Sullivan BP; Dorkin HL; Dovey M; Haver K; Martin T; Eaton RB
    J Pediatr; 2005 Sep; 147(3 Suppl):S98-100. PubMed ID: 16202793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL
    J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.